Target Name: LOC107984913
NCBI ID: G107984913
Review Report on LOC107984913 Target / Biomarker Content of Review Report on LOC107984913 Target / Biomarker
LOC107984913
Other Name(s): uncharacterized LOC107984913 | Uncharacterized LOC107984913

LOC107984913: A Promising Drug Target and Biomarker for Cancer

LOC107984913 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. Its function is not well understood, but it is known to play a role in the development and progression of certain diseases, such as cancer.

One of the most promising aspects of LOC107984913 is its potential as a drug target. Several studies have suggested that LOC107984913 may be involved in a variety of cellular processes that are important for cancer growth and progression, including cell signaling, angiogenesis, and inflammation.

In addition to its potential as a drug target, LOC107984913 has also been shown to be a potential biomarker for certain types of cancer. Several studies have shown that LOC107984913 can be detected in the blood or urine of patients with cancer, and that its levels are correlated with the severity of the disease. This suggests that LOC107984913 may be a useful diagnostic tool for certain types of cancer.

Overall, the study of LOC107984913 is still in its early stages, and much more research is needed to fully understand its role in the development and progression of cancer. However, its potential as a drug target and biomarker make it an important area of study, and one that could have significant implications for the treatment of certain types of cancer.

Protein Name: Uncharacterized LOC107984913

The "LOC107984913 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107984913 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC107984928 | LOC107984932 | LOC107984934 | LOC107984942 | LOC107984948 | LOC107984965 | LOC107984993 | LOC107985004 | LOC107985038 | LOC107985067 | LOC107985072 | LOC107985085 | LOC107985096 | LOC107985129 | LOC107985157 | LOC107985165 | LOC107985173 | LOC107985174 | LOC107985179 | LOC107985203 | LOC107985204 | LOC107985211 | LOC107985225 | LOC107985239 | LOC107985250 | LOC107985258 | LOC107985270 | LOC107985323 | LOC107985340 | LOC107985360 | LOC107985393 | LOC107985394 | LOC107985434 | LOC107985440 | LOC107985478 | LOC107985479 | LOC107985511 | LOC107985544 | LOC107985590 | LOC107985593 | LOC107985688 | LOC107985690 | LOC107985811 | LOC107985830 | LOC107985854 | LOC107985855 | LOC107985869 | LOC107985870 | LOC107985892 | LOC107985935 | LOC107985940 | LOC107985954 | LOC107985960 | LOC107985969 | LOC107985979 | LOC107985981 | LOC107985984 | LOC107985986 | LOC107985996 | LOC107986003 | LOC107986009 | LOC107986018 | LOC107986022 | LOC107986023 | LOC107986051 | LOC107986056 | LOC107986092 | LOC107986115 | LOC107986139 | LOC107986141 | LOC107986142 | LOC107986146 | LOC107986148 | LOC107986166 | LOC107986178 | LOC107986186 | LOC107986195 | LOC107986203 | LOC107986205 | LOC107986215 | LOC107986223 | LOC107986229 | LOC107986257 | LOC107986272 | LOC107986286 | LOC107986291 | LOC107986297 | LOC107986298 | LOC107986300 | LOC107986362 | LOC107986368 | LOC107986385 | LOC107986400 | LOC107986420 | LOC107986429 | LOC107986440 | LOC107986451 | LOC107986452 | LOC107986453 | LOC107986454